Huizhoushi Shengteng Innovation Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Huizhoushi Shengteng Innovation Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include INFISAN. The owner is based in Guangdong.
No. 25, Lingnan 2nd Lane, Pingshanyuan
Huidong County, Huizhou City
Guangdong 516300 , CN
Showing of trademarks Trademarks
Trademark Classifications
Huizhoushi Shengteng Innovation Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Huizhoushi Shengteng Innovation Technology Co., Ltd. have?
Huizhoushi Shengteng Innovation Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Huizhoushi Shengteng Innovation Technology Co., Ltd. file in?
Huizhoushi Shengteng Innovation Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Huizhoushi Shengteng Innovation Technology Co., Ltd.'s most well-known trademarks?
Huizhoushi Shengteng Innovation Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as INFISAN. These are among 1 currently registered trademark in the portfolio.
What is Huizhoushi Shengteng Innovation Technology Co., Ltd.'s trademark registration success rate?
Huizhoushi Shengteng Innovation Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.